Independent GDP Governance
for Pharmaceutical Transport

Independent audits and continuous monitoring of logistics providers — creating transparent GDP oversight for pharmaceutical companies and structured compliance documentation for logistics providers.

Audit
Audit

Independent GDP transport audits conducted at logistics providers.

Qualification
Qualification

Structured evaluation and qualification status of the transport provider.

Continuous monitoring
Continuous Monitoring

Ongoing monitoring of compliance performance and operational indicators.

CAPA oversight
CAPA Oversight

Tracking and verification of corrective and preventive actions.

Pharmaceutical Companies

Must ensure that their transport providers comply with GDP requirements — but often lack structured, continuous oversight mechanisms.

  • Independent transport audits
  • Structured provider qualification
  • Continuous compliance monitoring
  • CAPA tracking
  • Inspection-ready governance documentation
Pharmaceutical quality control
Cold chain logistics warehouse

Logistics Providers

Must demonstrate GDP compliance to pharmaceutical customers — but face repeated, overlapping audits from multiple clients.

  • Independent GDP transport audit
  • Structured compliance report
  • Qualification status
  • CAPA monitoring
  • Continuous compliance documentation

The GDP Governance Framework connects both sides.

An independent governance structure that creates a transparent compliance record for transport providers and structured oversight for pharmaceutical companies — replacing fragmented processes with a single, shared governance layer.

  • Independent of pharmaceutical companies and logistics providers
  • Structured governance documentation, ready for inspection
  • Replaces fragmented client-by-client audits with one shared layer
  • Continuous monitoring instead of one-off snapshots
  • Transparent compliance record across the supply chain
In practice, governance is often fragmented, with redundant audits along the supply chain. The GDP Governance Framework replaces this with a single, shared governance layer that both sides can rely on.
Manuel Kessen
Manuel Kessen
Founder, medipharma connect

How the Governance Process Works

A continuous governance cycle for pharmaceutical transport providers.

  1. 1.
    Initial GDP Transport Audit
  2. 2.
    Provider Qualification
  3. 3.
    Continuous Monitoring
  4. 4.
    CAPA Oversight & Documentation

Governance Reports

Delivery of governance reports that document compliance status and create transparency between pharmaceutical companies and logistics providers.

Inspection Report

A structured overview of the governance status of a logistics provider. Supports pharmaceutical companies during internal reviews and regulatory inspections.

GDP Governance
Inspection Report
Report No.
GDP-IR-2026-0041
Date
14 March 2026
Transport Provider
EuroTemp Logistics GmbH
Industriestraße 42 · 40789 Monheim am Rhein
Governance Summary
Qualification Status
Qualified
Compliance Score
88 / 100
Open CAPAs
2
Last Audit
14 Mar 2026
Next Review
Sep 2026
Audit Scope
The audit covered temperature-controlled transport operations including vehicle qualification, temperature monitoring systems, deviation management, and GDP training records. All active routes within the DACH region were included in scope.

Qualification Report

Enables logistics providers to demonstrate GDP compliance to existing or potential pharmaceutical customers.

GDP Qualification
Report
Report No.
GDP-QR-2026-0117
Date
28 March 2026
Company Profile
TransCold Logistics GmbH
Hafenweg 15 · 20457 Hamburg
GDP License: DE-GDP-2024-1189 · Fleet: 84 vehicles
Qualification Summary
Qualification Status
Active
Compliance Score
92 / 100
CAPA Status
All resolved
Last Audit
22 Feb 2026
Valid Until
Feb 2027
Service Scope
Temperature-controlled full-truck and groupage transport across EU/EEA. Active temperature ranges: +2 °C to +8 °C and +15 °C to +25 °C. Active and passive cooling systems. Real-time monitoring on all shipments.

Start the Conversation

If you work in pharmaceutical quality, supply chain or pharmaceutical logistics and would like to exchange views on GDP transport governance, we would be happy to connect.